Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD

Launched by UNIVERSITY HOSPITAL, BREST · Dec 21, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help patients with Chronic Obstructive Pulmonary Disease (COPD) improve their muscle strength and exercise ability through a method called neuromuscular electrical stimulation (NMES). The researchers want to find out if using NMES on both the thigh muscles (quadriceps) and the calf muscles (triceps surae) during pulmonary rehabilitation can lead to better results than just focusing on the thigh muscles alone. By strengthening both sets of muscles, the hope is to enhance overall exercise capacity, making it easier for patients to participate in daily activities and improve their quality of life.

To participate in this trial, individuals need to be diagnosed with COPD stages 2 to 4 and be at least 18 years old. They should also be able to provide consent and commit to the rehabilitation program. However, certain people may not qualify, such as those with recent lung surgeries, those who can't complete the program, or those with specific medical devices like pacemakers. If eligible, participants can expect to take part in a rehabilitation program that incorporates both standard exercises and the new NMES technique, with the goal of seeing improvements in their physical abilities.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient with COPD stages 2 to 4 (A to D) admitted to the Pulmonary Rehabilitation Department of the "Centre Hospitalier des Pays de Morlaix" or the "CHRU of Brest".
• • Patient aged 18 years or older.
• • Patient able to consent and having signed a consent form.
• Exclusion Criteria:
• • Patient with a history of pneumonectomy, lobectomy dated less than 6 months old
• • Patient with an inability to complete a respiratory rehabilitation program in its entirety
• • Patient under guardianship or curatorship
• • Person equipped with electronic devices such as pacemakers and intracardiac defibrillators.
• • Skin lesions and infectious foci on the area where the electrodes.
• • Pregnant or breastfeeding women